Moreover, some genetic alterations (mostly involving JAK/STAT pathways, DDX3X, and TP53) have been reported, mainly in aggressive EBV-positive T/NK LPD. The gene discussed is TP53; the disease is disseminated peritoneal leiomyomatosis.